Trials / Recruiting
RecruitingNCT03842475
Who Will Benefit From Bariatric Surgery for Diabetes?
Who Will Benefit From Bariatric Surgery for Diabetes? Using Fat Distribution Measurement, Gut Hormone Profiles and Genetic Data to Predict Diabetes Remission
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 210 (estimated)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
A study investigating the influence of fat distribution, genetic susceptibility markers for type 2 diabetes (T2DM) and fat distribution, epigenetic and transcriptomic changes and gut hormone responses to a mixed meal on diabetes remission following bariatric surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Roux-en-Y gastric bypass (RYGB) | Bariatric surgery |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2025-01-01
- Completion
- 2028-10-05
- First posted
- 2019-02-15
- Last updated
- 2023-04-19
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03842475. Inclusion in this directory is not an endorsement.